Innoviva (INVA) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 79.36% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 29.25% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -16.86% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.78% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 40.09% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 67.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.96% |
| Sep 30, 2025 | 1,962.80% |
| Jun 30, 2025 | 83.16% |
| Mar 31, 2025 | 71.19% |
| Sep 30, 2024 | -27.75% |
| Jun 30, 2024 | -22.62% |
| Mar 31, 2024 | -14.72% |
| Sep 30, 2023 | 2.15% |
| Jun 30, 2023 | -28.71% |
| Mar 31, 2023 | -29.11% |
| Sep 30, 2022 | -95.77% |
| Jun 30, 2022 | -30.00% |
| Mar 31, 2022 | -31.19% |
| Sep 30, 2021 | 21.49% |
| Jun 30, 2021 | 28.12% |
| Mar 31, 2021 | -30.41% |
| Dec 31, 2020 | -40.31% |
| Sep 30, 2020 | 42.91% |
| Jun 30, 2020 | 61.85% |
| Mar 31, 2020 | 94.35% |
| Dec 31, 2019 | 75.67% |
| Sep 30, 2019 | 82.51% |
| Jun 30, 2019 | 86.80% |
| Mar 31, 2019 | 103.92% |
| Dec 31, 2018 | 133.42% |
| Sep 30, 2018 | 157.38% |
| Jun 30, 2018 | 190.83% |
| Mar 31, 2018 | 349.21% |
| Dec 31, 2017 | 460.30% |
| Sep 30, 2017 | 116.42% |
| Jun 30, 2017 | 83.04% |
| Mar 31, 2017 | 31.16% |
| Dec 31, 2016 | 38.53% |
| Sep 30, 2016 | 36.19% |
| Jun 30, 2016 | 41.99% |
| Mar 31, 2016 | 28.24% |
| Dec 31, 2015 | 26.98% |
| Sep 30, 2015 | 26.60% |
| Jun 30, 2015 | 26.34% |
| Mar 31, 2015 | -89.92% |
| Dec 31, 2014 | 26.00% |
| Sep 30, 2014 | 65.86% |
| Jun 30, 2014 | 60.77% |
| Mar 31, 2014 | 14.06% |
| Dec 31, 2013 | 28.23% |
| Sep 30, 2013 | 32.40% |
| Jun 30, 2013 | 43.86% |